Tag Archives: fshcx

4 Top-Ranked Healthcare Mutual Funds To Boost Your Return

When markets are plying through choppy waters, investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary so much with market conditions, making them a safe haven in difficult times. Many pharma companies also generate regular dividends, which go a long way in softening the blow dealt by plummeting share prices. Mutual funds are the perfect choice for investors looking to enter this sector, since they possess the advantages of wide diversification and analytical insight. Below, we share with you 4 top-rated healthcare mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy), and we expect each fund to outperform its peers in the future. To view the Zacks Rank and past performance of all healthcare mutual funds, click here . Fidelity Select Pharmaceuticals Portfolio No Load (MUTF: FPHAX ) seeks growth of capital. The fund invests a lion’s share of its assets in securities of companies involved in operations, including manufacturing, distribution and development of pharmaceuticals and drugs. It generally focuses on acquiring common stocks of companies located throughout the globe. Factors including economic condition and financial strength are taken into consideration before investing in securities of a company. The Fidelity Select Pharmaceuticals Portfolio No Load is a non-diversified fund and has a three-year annualized return of 22.9%. Asher Anolic has been the fund manager of FPHAX since 2013. T. Rowe Price Health Sciences Fund No Load (MUTF: PRHSX ) invests a major portion of its assets in common stocks of companies whose primary operations are related to health sciences. It focuses on investing in large and mid-cap firms. The T. Rowe Price Health Sciences Fund No Load has a three-year annualized return of 30%. As of September 2015, PRHSX held 160 issues, with 4.97% of its assets invested in Allergan plc (NYSE: AGN ). Vanguard Health Care Fund Investor (MUTF: VGHCX ) seeks long-term capital growth. The fund invests a large chunk of its assets in securities of companies primarily involved in operations related to the healthcare domain. VGHCX invests in healthcare companies, including pharmaceutical firms, medical supply companies and companies engaged in operations related to medical and biochemical. It may invest a maximum of half of its assets in companies located in foreign lands. The Vanguard Health Care Fund Investor has a three-year annualized return of 26.8%. VGHCX has an expense ratio of 0.34%, as compared to the category average of 1.33%. Fidelity Select Medical Delivery Portfolio No Load (MUTF: FSHCX ) invests the majority of its assets in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. It focuses on acquiring common stocks of issuers all over the world. The Fidelity Select Medical Delivery Portfolio No Load fund has a three-year annualized return of 20.8%. As of October 2015, the fund held 47 issues, with 19.06% of its assets invested in UnitedHealth Group Inc (NYSE: UNH ). Original Post

5 Top-Rated Healthcare Mutual Funds To Add To Your Portfolio

Healthcare mutual funds provide excellent choices for investors looking to enter this safe-haven sector, which is likely to protect their investment during a market downturn. The healthcare sector has proven to be one of the most desirable avenues during difficult times as it does not vary with market conditions. Also, several pharmaceutical companies have a history of paying regular dividends, which can help to offset the losses from plummeting share prices. Below we will share with you 5 top-ranked healthcare mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. FSPHX invests a major portion of its assets in companies involved in designing, manufacturing and selling healthcare products and services. FSPHX invests in companies across the world. The Fidelity Select Health Care Portfolio is a non-diversified fund and has returned 10.6% over the past one year. FSPHX has an expense ratio of 0.74% as compared to a category average of 1.35%. Fidelity Select Biotechnology Portfolio (MUTF: FBIOX ) invests a large share of its assets in companies primarily involved in research, development, manufacture and distribution of various biotechnological products. Factors such as financial strength and economic conditions are considered to invest in companies located anywhere in the world. The Fidelity Select Biotechnology Portfolio is a non-diversified fund and has returned 22.7% over the past one year. Rajiv Kaul is the fund manager and has managed FBIOX since 2005. Turner Medical Sciences Long/Short C (MUTF: TMSCX ) seeks capital appreciation. TMSCX invests a major chunk of its assets in healthcare firms. TMSCX uses a long/short growth strategy for reduction of volatility and capital preservation during a market downturn. TMSCX mainly focuses on acquiring securities of companies having market capitalizations greater than $250 million. TMSCX is expected to maintain a portfolio of 15 to 75 securities long, and 15 to 75 securities short. The Turner Medical Sciences Long/Short C has returned 11.1% over the past one year. TMSCX has an expense ratio of 1.50% as compared to a category average of 1.84%. Fidelity Select Medical Delivery Portfolio (MUTF: FSHCX ) invests largely in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. FSHCX focuses on acquiring common stocks of both US and non-US companies. The Fidelity Select Medical Delivery Portfolio fund is non-diversified and has returned 19.9% over the last one-year period. Steven Bullock is the fund manager and has managed FSHCX since 2012. Fidelity Select Medical Equipment & Systems (MUTF: FSMEX ) seeks capital growth. FSMEX invests the majority of its assets in companies that are primarily involved in medical equipment and devices and the related technologies sector. FSMEX focuses on acquiring common stocks of companies by analyzing factors including financial strength and economic condition. FSMEX invests in both US and non-US companies. The Fidelity Select Medical Equipment & Systems is a non-diversified fund and has returned almost 14.3% over the past one year. As of August 2015, FSMEX held 55 issues with 23.57% of its assets invested in Medtronic PLC. Original Post

3 Healthcare Funds To Buy As Supreme Court Upholds ObamaCare

Fund holdings, ETF investing “}); $$(‘#article_top_info .info_content div’)[0].insert({bottom: $(‘mover’)}); } $(‘article_top_info’).addClassName(test_version); } SeekingAlpha.Initializer.onDOMLoad(function(){ setEvents();}); The Supreme Court has ruled 6-3 to uphold a key provision of the Affordable Care Act. The Supreme Court ruling holds that the Affordable Care Act can authorize federal tax credits for eligible Americans living not just in states with their own exchanges but also in the states that use the federal market place. This decision is not only a major win for the Obama Administration, it is also a win for healthcare companies. After the announcement, the S&P 500 healthcare index rose .85 percent and many hospital stocks enjoyed gains of 8 percent and above. These reactions from the market, show that Wall Street views the Supreme Court decision as a positive sign for the continuance of strong growth in the healthcare sector. With this Supreme Court decision and the historical steadiness of the healthcare sector, it would be wise to consider investing in this sector or increasing your investment exposure. Below we will share with you 3 buy-ranked healthcare mutual funds. Each has earned either a Zacks Mutual Fund Rank #1 (Strong Buy) or a Zacks Mutual Fund Rank #2 (Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Medical Delivery Portfolio (MUTF: FSHCX ) seeks long-term capital growth. FSHCX invests a major portion of its assets mainly involved in operations related to hospitals, nursing homes and other organizations engaged in providing healthcare services. FSHCX primarily focuses on acquiring common stocks of companies throughout the globe. Factors including financial strength and economic conditions are considered to invest in a company. The Fidelity Select Medical Delivery Portfolio fund is non-diversified and has returned 17.1% in the year-to-date frame. FSHCX has an expense ratio of 0.79% as compared to a category average of 1.37%. Turner Medical Sciences Long/Short C (MUTF: TMSCX ) invests a large chunk of its assets in healthcare firms. TMSCX uses a long/short growth strategy for reduction of volatility and capital preservation during market downturns. TMSCX mainly focuses on acquiring securities of companies having market capitalizations greater than $250 million. TMSCX is expected to maintain a portfolio of 15 to 75 securities long, and 15 to 75 securities short. The Turner Medical Sciences Long/Short C fund has returned 27.6% in the year-to-date frame. As of May 2015, TMSCX held 40 issues with 4.96% of its assets invested in Prothena Corp. pls (NASDAQ: PRTA ). Janus Global Life Sciences D (MUTF: JNGLX ) seeks capital appreciation over the long run. JNGLX invests the lion’s share of its assets in securities of life science oriented companies. JNGLX invests a minimum of one-fourth of its assets in firms from the “life sciences” domain. The Janus Global Life Sciences D fund has returned 21.8% in the year-to-date frame. Andrew Acker is the fund manager and has managed JNGLX since 2007. Original Post Share this article with a colleague